The team at Mind Matters Psychiatry & Weight Loss in Longwood, Florida, specializes in evidence-based medical weight-loss programs, including GLP-1 therapies such as semaglutide and tirzepatide.
Initiation of SGLT2 inhibitors and GLP-1 receptor agonists according to level of frailty in people with type 2 diabetes and cardiovascular disease in Denmark: a cross-sectional, nationwide study
Good candidates are those committed to making sustainable lifestyle changes alongside medication
A physician-supervised plan can help answer the questions that matter most: Is this medication appropriate based on your medical history
Carefully document your care Sometimes you may have to file multiple appeals if the first one is unsuccessful, says Tracy Zvenyach, the vice president for advocacy and research at the nonprofit Obesity Action Coalition, which receives financial support from drugmakers including Zepbound maker Eli Lilly and Wegovy producer Novo Nordisk
Recent evidence suggests that episodes of ketoacidosis can also occur [69], and it might be of particular concern among insulin-deficient individuals, including those with longstanding T2D, T1D, or latent autoimmune diabetes in adults (LADA) [70]